XML 43 R20.htm IDEA: XBRL DOCUMENT

Supplemental Financial Information

3 Months Ended

Mar. 31, 2021

Balance Sheet Related Disclosures [Abstract]

Note 14. Supplemental Financial Information

Inventories consisted of the following (in thousands):


	March 31, 2021		December 31, 2020
Raw materials	$	42,907	$	43,257
Work-in-process	9,755		8,055
Finished goods	71,861		75,363
	$	124,523	$	126,675

As of March 31, 2021 and December 31, 2020, inventories include adjustments totaling $4.0 million and $6.6 million, respectively, to record balances at lower of cost or net realizable value.

Accrued liabilities and other consisted of the following (in thousands):


	March 31, 2021		December 31, 2020
Legal and administrative costs	$	15,650	$	15,820
Operating lease liabilities	11,535		11,276
Contingent consideration (1)	9,424		13,968
Contract liabilities	9,234		6,929
Restructuring related liabilities (2)	5,569		6,258
Derivative contract liabilities (3)	2,065		7,372
Research and development costs	4,752		4,257
Provisions for agents, returns and other	2,377		3,063
Other accrued expenses	31,428		26,465
	$	92,034	$	95,408

(1)Refer to “Note 5. Fair Value Measurements”

(2)Refer to “Note 3. Restructuring”

(3)Refer to “Note 7. Derivatives and Risk Management”

As of March 31, 2021 and December 31, 2020, contract liabilities of $9.5 million and $8.6 million, respectively, are included within accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets.